Overview

A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
To compare the safety and efficacy of an aliskiren-based regimen to a lisinopril-based regimen in the treatment of severe hypertension
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Lisinopril